THE ASSOCIATION BETWEEN MIDLIFE BLOOD-PRESSURE LEVELS AND LATE-LIFE COGNITIVE FUNCTION - THE HONOLULU-ASIA AGING STUDY

Objective.-To assess the long-term relationship of midlife blood press ure levels to late-life cognitive function. Design.-The 4678 surviving cohort members of the prospective Honolulu Heart Program (baseline, 1 965-1968) were examined a fourth time in 1991 through 1993 and given a cognitive test. Participants.-The subjects were 3735 Japanese-America n men living in Hawaii in the community or in institutions, with an av erage age of 78 years at the fourth examination. Main Outcome Measures .-Cognitive function, measured by the 100-point Cognitive Abilities Sc reening Instrument (CASI), was categorized into good (reference: a CAS I score of 92 to 100), intermediate (<92 to 82), and poor (<82). Midli fe systolic blood pressure (SEP) and diastolic blood pressure (DBP) va lues were measured in 1965, 1968, and 1971. A respondent was classifie d into the following categories if two of three measurements fell into the following groups: for SEP, <110, 110 to 139, 140 to 159, and grea ter than or equal to 160 mm Hg; and for DBP, <80, 80 to 89, 90 to 94, and greater than or equal to 95 mm Hg. Results.-When we controlled for age and education, the risk for intermediate and poor cognitive funct ion increased progressively with increasing level of midlife SEP categ ory (P for trend <.03 and <.001, respectively). for every 10-mm Hg inc rease in SEP there was an increase in risk for intermediate cognitive function of 7% (95% confidence interval [C], 3% to 11%) and for poor c ognitive function of 9% (95% CI, 3% to 16%). Adjustment for prevalent stroke, coronary heart disease, and subclinical atherosclerosis reduce d the strength of the relationship between midlife SEP and poor cognit ive function to 5% (95% CI, 0% to 12%). The level of cognitive functio n was not associated with midlife DBP. Conclusions.-Midlife SEP is a s ignificant predictor of reduced cognitive function in later life. Earl y control of SEP levels may reduce the risk for cognitive impairment i n old age.